empirical-ceo-dawn-lissyPresident & CEO

Dawn Lissy is a biomedical engineer, an entrepreneur and an innovator. For more than 20 years, she’s worked with clients to bring groundbreaking medical devices to market.

Since 2001, she has participated in ASTM committees focusing on orthopedic devices, including committee F04.25 (for spinal implant devices), F04.21 (for osteosynthesis) and F04.22 (for orthopedic implant devices). Dawn’s drive to develop scientifically based test results and deliver outstanding customer service throughout her clients’ product development cycles is reflected in the work she conducts to educate customers, vendors and regulatory bodies alike.

She was recently selected for the FDA’s Entrepreneurs-in-Residence program, which invited top professionals from the medical device industry to work with the FDA to streamline and improve the approval process for devices. Her close contact with regulatory officials enables her to keep Empirical clients and peers abreast of all ASTM, FDA and CE regulations that may affect product testing and development. She’s frequently invited to share her expertise at biomedical events and conferences around the world. She also volunteers for the Perry Initiative, a nonprofit dedicated to bringing more women into engineering and orthopedic surgery.

Since 1998, the Empirical family of companies (Empirical Testing, Empirical Machine and Empirical Consulting) has operated under Dawn’s direction. She has been responsible for all Empirical operations, including designing test fixtures and protocols, running test protocols, and writing complete reports. She holds an inventor patent (US Patent Number 6159211) for the Stackable Cage System for Corpectomy and Vertebrectomy. She is a member of the Biomedical Engineering Society, Society of Women Engineers, the American Society of Biomechanics and the American Society for Testing and Materials. She holds a master’s degree in biomedical engineering from The University of Akron in Ohio.